China Medical & HealthCare Group Limited provided unaudited consolidated earnings guidance for the eighteen months ended 31 December 2019. For the period, the company expected to record a substantial reduction in loss or may record a small profit attributable to shareholders of the Company in a range of approximately HKD 1 million to HKD 13 million.